DVHGF (Devonian Health Group) Forward Dividend Yield % : 0.00% (As of Dec. 13, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Devonian Health Group Forward Dividend Yield %?

As of today (2024-12-13), the Forward Annual Dividend Yield of Devonian Health Group is 0.00%.

As of today (2024-12-13), the Trailing Annual Dividend Yield of Devonian Health Group is 0.00%.

DVHGF's Forward Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.5
* Ranked among companies with meaningful Forward Dividend Yield % only.

Devonian Health Group's Dividends per Share for the three months ended in Jul. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Devonian Health Group's Forward Dividend Yield %

For the Biotechnology subindustry, Devonian Health Group's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Devonian Health Group's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's Forward Dividend Yield % falls into.

Devonian Health Group Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Devonian Health Group (OTCPK:DVHGF) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Devonian Health Group Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Devonian Health Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (OTCPK:DVHGF) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

GSD:Canada

Address

360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1

Website

https://www.groupedevonian.com

Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

From GuruFocus

Devonian Announces the Closing of a $315,000 Private Placement and an Additional Loan of $500,000

By GlobeNewswire GlobeNewswire • 08-22-2019